(WCH) Wacker Chemie - Overview

Sector: Basic Materials | Industry: Specialty Chemicals | Exchange: XETRA (Germany) | Market Cap: 4.928m EUR | Total Return: 66.1% in 12m

Silicones, Polymers, Polysilicon, Biosolutions
Total Rating 67
Safety 81
Buy Signal 1.60
Specialty Chemicals
Industry Rotation: -2.6
Market Cap: 5.73B
Avg Turnover: 11.3M
Risk 3d forecast
Volatility38.4%
VaR 5th Pctl6.60%
VaR vs Median4.23%
Reward TTM
Sharpe Ratio1.23
Rel. Str. IBD85.8
Rel. Str. Peer Group83.3
Character TTM
Beta0.305
Beta Downside0.172
Hurst Exponent0.377
Drawdowns 3y
Max DD56.64%
CAGR/Max DD-0.09
CAGR/Mean DD-0.14
EPS (Earnings per Share) EPS (Earnings per Share) of WCH over the last years for every Quarter: "2021-03": 2.06, "2021-06": 3.5, "2021-09": 4.9, "2021-12": 5.77, "2022-03": 7.92, "2022-06": 7.67, "2022-09": 5.08, "2022-12": 4.51, "2023-03": 2.9, "2023-06": 2.38, "2023-09": 0.56, "2023-12": 0.46, "2024-03": 0.89, "2024-06": 0.58, "2024-09": 0.56, "2024-12": 2.81, "2025-03": -0.16, "2025-06": -0.49, "2025-09": -1.73, "2025-12": -14.15, "2026-03": 0.21,
Last SUE: 0.11
Qual. Beats: 0
Revenue Revenue of WCH over the last years for every Quarter: 2021-03: 1359.6, 2021-06: 1501, 2021-09: 1658.6, 2021-12: 1688.3, 2022-03: 2076.2, 2022-06: 4250.4, 2022-09: 2132.2, 2022-12: 1826.7, 2023-03: 1744, 2023-06: 1752.8, 2023-09: 1522.8, 2023-12: 1382.6, 2024-03: 1489.5, 2024-06: 1467.9, 2024-09: 1429.6, 2024-12: 1334.8, 2025-03: 1478.3, 2025-06: 1412.9, 2025-09: 1340.3, 2025-12: 1255, 2026-03: 1405.6,
Rev. CAGR: -9.32%
Rev. Trend: -90.9%
Last SUE: 4.00
Qual. Beats: 1

Warnings

Share dilution 47.6% YoY

Interest Coverage Ratio -0.2 is critical

Tailwinds

Supp Ema20, Leader, Tailwind, Avwap Ph Week, Confidence

Description: WCH Wacker Chemie

Wacker Chemie AG is a Munich-based specialty chemicals manufacturer operating across four primary segments: Silicones, Polymers, Biosolutions, and Polysilicon. The company supplies critical raw materials, such as hyperpure polysilicon and silicone elastomers, to high-growth industries including semiconductors, photovoltaics, automotive, and pharmaceuticals.

The business model relies on integrated production sites, known as Verbund sites, where by-products from one process serve as raw materials for another to maximize resource efficiency. As a key supplier to the solar and chip industries, Wacker Chemie is highly sensitive to global energy costs and fluctuations in the polysilicon pricing cycle. For a deeper dive into these valuation drivers, consider exploring the data on ValueRay.

Founded in 1914, the company maintains a global footprint with significant export operations in Europe, Asia, and the Americas. It remains a subsidiary of Dr. Alexander Wacker Familiengesellschaft mbH, reflecting a long-term family-controlled ownership structure common in the German industrial sector.

Headlines to Watch Out For
  • Global solar PV demand fluctuations impact high-purity polysilicon pricing and margins
  • Energy cost volatility in German manufacturing sites affects chemical production profitability
  • Semiconductor industry capital expenditure cycles drive demand for hyperpure silicon wafers
  • Construction market activity levels dictate volume growth for polymer and silicone binders
  • Rapid expansion of biopharma production capacity influences long-term revenue diversification goals
Piotroski VR‑10 (Strict) 3.0
Net Income: -797.9m TTM > 0 and > 6% of Revenue
FCF/TA: 0.00 > 0.02 and ΔFCF/TA 7.86 > 1.0
NWC/Revenue: 49.09% < 20% (prev 43.75%; Δ 5.34% < -1%)
CFO/TA 0.07 > 3% & CFO 588.4m > Net Income -797.9m
Net Debt (1.18b) to EBITDA (450.3m): 2.63 < 3
Current Ratio: 2.99 > 1.5 & < 3
Outstanding Shares: last quarter (72.9m) vs 12m ago 47.56% < -2%
Gross Margin: 12.68% > 18% (prev 0.17%; Δ 1.25k% > 0.5%)
Asset Turnover: 61.45% > 50% (prev 62.60%; Δ -1.15% > 0%)
Interest Coverage Ratio: -0.16 > 6 (EBITDA TTM 450.3m / Interest Expense TTM 278.7m)
Altman Z'' 4.07
A: 0.31 (Total Current Assets 3.99b - Total Current Liabilities 1.34b) / Total Assets 8.50b
B: 0.39 (Retained Earnings 3.28b / Total Assets 8.50b)
C: -0.01 (EBIT TTM -45.8m / Avg Total Assets 8.81b)
D: 0.76 (Book Value of Equity 3.54b / Total Liabilities 4.68b)
Altman-Z'' = 4.07 = AA
Beneish M -2.97
DSRI: 1.21 (Receivables 1.01b/880.3m, Revenue 5.41b/5.71b)
GMI: 1.34 (GM 12.68% / 16.95%)
AQI: 0.63 (AQ_t 0.12 / AQ_t-1 0.18)
SGI: 0.95 (Revenue 5.41b / 5.71b)
TATA: -0.16 (NI -797.9m - CFO 588.4m) / TA 8.50b)
Beneish M = -2.97 (Cap -4..+1) = A
What is the price of WCH shares? As of May 23, 2026, the stock is trading at EUR 97.25 with a total of 59,487 shares traded.
Over the past week, the price has changed by +2.52%, over one month by +4.58%, over three months by +29.55% and over the past year by +66.07%.
Is WCH a buy, sell or hold? Wacker Chemie has no consensus analysts rating.
What are the forecasts/targets for the WCH price?
Analysts Target Price - -
Wacker Chemie (WCH) - Fundamental Data Overview as of 18 May 2026
Market Cap USD = 5.73b (4.93b EUR * 1.1625 EUR.USD)
P/E Forward = 21.9298
P/S = 0.8984
P/B = 1.2823
P/EG = 5.1721
Revenue TTM = 5.41b EUR
EBIT TTM = -45.8m EUR
EBITDA TTM = 450.3m EUR
Long Term Debt = 1.93b EUR (from longTermDebt, last fiscal year)
Short Term Debt = 161.8m EUR (from shortTermDebt, last fiscal year)
Debt = 2.69b EUR (from shortLongTermDebtTotal, last fiscal year) + Leases 323.0m
Net Debt = 1.18b EUR (calculated: Debt 2.69b - CCE 1.51b)
Enterprise Value = 6.11b EUR (4.93b + Debt 2.69b - CCE 1.51b)
Interest Coverage Ratio = -0.16 (Ebit TTM -45.8m / Interest Expense TTM 278.7m)
EV/FCF = 173.6x (Enterprise Value 6.11b / FCF TTM 35.2m)
FCF Yield = 0.58% (FCF TTM 35.2m / Enterprise Value 6.11b)
FCF Margin = 0.65% (FCF TTM 35.2m / Revenue TTM 5.41b)
Net Margin = -14.74% (Net Income TTM -797.9m / Revenue TTM 5.41b)
Gross Margin = 12.68% ((Revenue TTM 5.41b - Cost of Revenue TTM 4.73b) / Revenue TTM)
Gross Margin QoQ = 15.63% (prev 11.73%)
Tobins Q-Ratio = 0.72 (Enterprise Value 6.11b / Total Assets 8.50b)
Interest Expense / Debt = 0.98% (Interest Expense 26.5m / Debt 2.69b)
Taxrate = 40.47% (10.4m / 25.7m)
NOPAT = -27.3m (EBIT -45.8m * (1 - 40.47%)) [loss with tax shield]
Current Ratio = 2.99 (Total Current Assets 3.99b / Total Current Liabilities 1.34b)
Debt / Equity = 0.74 (Debt 2.69b / totalStockholderEquity, last quarter 3.65b)
Debt / EBITDA = 2.63 (Net Debt 1.18b / EBITDA 450.3m)
Debt / FCF = 33.62 (Net Debt 1.18b / FCF TTM 35.2m)
Total Stockholder Equity = 3.97b (last 4 quarters mean from totalStockholderEquity)
RoA = -9.06% (Net Income -797.9m / Total Assets 8.50b)
RoE = -20.12% (Net Income TTM -797.9m / Total Stockholder Equity 3.97b)
RoCE = -0.78% (EBIT -45.8m / Capital Employed (Equity 3.97b + L.T.Debt 1.93b))
 RoIC = -0.47% (negative operating profit) (NOPAT -27.3m / Invested Capital 5.81b)
 WACC = 4.77% (E(4.93b)/V(7.62b) * Re(7.06%) + D(2.69b)/V(7.62b) * Rd(0.98%) * (1-Tc(0.40)))
Discount Rate = 7.06% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares (quarterly) Correlation: 4.60 | Cagr: 18.55%
[DCF] Terminal Value 80.82% ; FCFF base≈35.2m ; Y1≈23.1m ; Y5≈10.6m
 [DCF] Fair Price = N/A (negative equity: EV 335.5m - Net Debt 1.18b = -848.1m; debt exceeds intrinsic value)
 EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.11 | # QB: 0
Revenue Correlation: -90.86 | Revenue CAGR: -9.32% | SUE: 4.0 | # QB: 1
EPS current Quarter (2026-06-30): EPS=1.12 | Chg30d=+2700.00% | Revisions=+20% | Analysts=1
EPS next Quarter (2026-09-30): EPS=0.68 | Chg30d=+326.67% | Revisions=+20% | Analysts=1
EPS current Year (2026-12-31): EPS=0.71 | Chg30d=N/A | Revisions=+20% | GrowthEPS=+111.5% | GrowthRev=+4.5%
EPS next Year (2027-12-31): EPS=2.38 | Chg30d=+4.35% | Revisions=+50% | GrowthEPS=+234.2% | GrowthRev=+1.9%
[Analyst] Revisions Ratio: +50%